Atlas Trials

Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%

Clinical trial NCT01892137 · COMPLETED

Trial details

NCT number
NCT01892137
Sponsor
LEO Pharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Actinic Keratosis
Start date
2013-07-01
Primary completion
2014-03-01
Enrollment
137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.